Journal of Medicinal Chemistry p. 1222 - 1225 (1978)
Update date:2022-08-04
Topics:
Fondy
Roberts
Tsiftsoglou
Sartorelli
2-Deoxy-2(haloacetamido)-D-glucose and 2-deoxy-2-(haloacetamido)-D-galactose (fluoro, chloro, and bromo) were prepared by de-O-acetylation of the appropriate 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(haloacetamido)-β-D-hexose with triethylamine. The 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(chloroacetamido)- and 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(bromoacetamido)-β-D-hexoses were produced by condensation of a haloacetyl anhydride with 1,3,4,6-tetra-O-acetyl-2-amino-2-deoxy-β-D-hexose hydrochloride in pyridine. The hydrochlorides were converted to free bases for condensation with fluoroacetic acid in the presence of dicyclohexylcarbodiimide to produce 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(fluoroacetamido)-β-D-hexoses. The chloroacetamido and bromoacetamido derivatives were from 3- to 12-fold more toxic on a molar basis to BDF1 mice when administerd as lipophilic tetra-O-acetates than as the free sugars; no significant difference existed between the glucose and galactose forms. The fluoroacetamido analogue of the glucose series was fivefold more toxic than the comparable fluoroacetamido derivative of the galactose series; no difference existed in the toxicities of the free sugars and the tetra-O-acetates with either of the fluoseries; no difference existed in the toxicities of the free sugars and the tetra-O-acetates with either of the fluoroacetamide-containing hexoses. Cytotoxicity against log-phase cultured Friend erythroleukemia cells was greatest with the tetra-O-acetylated bromoacetamido derivatives in both the gluco and galacto series, these agents being three- to fourfold more cytotoxic than tetra-O-acetylated chloroacetamido derivatives and 20-fold more cytotoxic than tetra-O-acetylated fluoroacetamido sugars. The N-chloroacetamido derivative in the glucose series was 50-fold more cytotoxic as the tetra-O-acetate than as the free nonacetylated sugar. These results support the concept that tetra-O-acetylated derivatives of the chloroacetamido and bromoacetamido carbohydrate analogues function as lipophilic alkylating agents and lose biological activity when converted to hydrophilic free hydroxyl forms, whereas the fluoroacetamido derivatives exert their effects as the de-O-acetylated form.
View MoreLonzeal Pharmaceuticals Co., Ltd.
website:http://www.lonzeal.com
Contact:+86-13381011962
Address:RM 801, Yue MOMA, No. 26 Anningzhuang Rd. Haidian District, Beijing, China
Wuhan Hanye Chemical New Material Co.,Ltd
Contact:+86-27-85308141
Address:LiuDian, Panlongcheng Economic Development Zone, HuangPi district, Wuhan, Hubei 430311 P.R.China
Chongqing Rong&Quan Pharmaceutical Technology Co. , Ltd.
Contact:86-023-65268721
Address:No. 7, Manshanhong Village, Pingdingshan, Shapingba District, Chongqing Province, China
Shanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
Jiangxi Hito Chemical Co., Ltd.
Contact:+86-792-3170318
Address:No. 6, Tianhong Ave., Xinghuo Industry Park, Yongxiu, Jiujiang, Jiangxi, China
Doi:10.1002/chem.200305427
(2004)Doi:10.1016/j.ejmech.2019.111622
(2019)Doi:10.1021/acs.joc.9b00870
(2019)Doi:10.1016/j.tet.2006.04.071
(2006)Doi:10.1039/c39950001699
(1995)Doi:10.1021/ja01559a050
(1957)